News
09-20-2013, 10:31 PM
Applied Integrin Sciences, Inc. announced today that its first cancer therapeutic drug candidate eliminated all intraperitoneal ovarian cancer tumors in a pre-clinical study testing a novel treatment regimen.
More... (http://www.news-medical.net/news/20130921/Applied-Integrin-Sciences-drug-candidate-eliminates-ovarian-cancer-tumors-in-pre-clinical-study.aspx)
More... (http://www.news-medical.net/news/20130921/Applied-Integrin-Sciences-drug-candidate-eliminates-ovarian-cancer-tumors-in-pre-clinical-study.aspx)